Marilyn Moy, MD
Adjunct Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Pulmonary, Allergy, Sleep & Critical Care Medicine

MD, Harvard Medical School
MSc, Harvard School of Public Health
AB, Radcliffe College



Marilyn L. Moy, M.D., M.Sc., Associate Professor of Medicine, Harvard Medical School, is a Staff Pulmonary Physician at VA Boston Healthcare System. She is Medical Director of the Pulmonary Rehabilitation Program, accredited by the American Association of Cardiovascular and Pulmonary Rehabilitation. Dr. Moy studies the role of physical activity (PA) in the risk stratification of COPD, technology-based interventions to promote PA, and the biological mechanisms underlying the beneficial effects of PA on COPD outcomes. Her work has contributed to the field of telehealth medicine.

Dr. Moy is internationally recognized as an expert in Pulmonary Rehabilitation. She was the 2016-2017 Chair of the Program Committee of the Rehabilitation Assembly of the American Thoracic Society. She has been an invited speaker at the European Respiratory Congress in Munich, Germany and Amsterdam, Holland. She serves on the Research Advocacy Committee of the ATS.

As the Principal Investigator on VA and NIH funded grants, Dr. Moy published one of the first papers demonstrating that low PA is associated with increased risk for acute exacerbations in COPD. Dr. Moy has developed a novel internet-mediated, pedometer based intervention to promote PA in COPD. Her work was recognized with the 2017 Massachusetts Pulmonary Section award for best clinical research abstract. Dr. Moy also examines biological mechanisms including the relationship between PA and telomere length, and the epigenetic changes associated with improvements in PA. Dr. Moy is VA Boston's 2017 nominee for the Presidential Early Career Award for Scientists and Engineers.

Dr. Moy is a Co-Investigator for a pragmatic trial examining a PA coaching intervention (PCORI), and a trial on the efficacy of Tai Chi to maintain benefits after conventional pulmonary rehabilitation in COPD (NIH-NCCIH). Dr. Moy has been the site-PI for NHLBI clinical trials.

VA Boston Healthcare System






Title
Long-term Oxygen Treatment Trial (LOTT)
(PI)

Prospective Randomized Placebo-Controlled Trial of Simvastatin in the Prevention of COPD Exacerbations (STATCOPE)
(PI)

BEAM COPD Study: Breathing, Education, Awareness and Movement
(PI)

Intervention Study in overweiGHT patients with COPD (INSIGHT)
(PI)

Patient-centered Physical Activity Coaching in COPD: A Pragmatic Trial
(PI)

Breathing, Education, Awareness, and Movement after Pulmonary Rehabilitation
(PI)

Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
(PI)



Yr Title Project-Sub Proj Pubs
2024 The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans with COPD and Chronic Musculoskeletal Pain 5I01RX004225-02
2024 REhabilitation Promoting Prevention And Improved Resilience (REPPAIR) 5I50RX003430-04
2024 Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD 5I01RX002855-06
2023 The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans with COPD and Chronic Musculoskeletal Pain 1I01RX004225-01A1
2023 Effects of Chronic Pain, Dyspnea, and Physical Activity Promotion on Functional Connectivity of the Brain in COPD 5I21RX003305-04
2023 Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD 5I01RX002855-05
2022 REhabilitation Promoting Prevention And Improved Resilience (REPPAIR) 5I50RX003430-02
2022 Effects of Chronic Pain, Dyspnea, and Physical Activity Promotion on Functional Connectivity of the Brain in COPD 5I21RX003305-03
2022 Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD 5I01RX002855-04
2021 REhabilitation Promoting Prevention And Improved Resilience (REPPAIR) 1I50RX003430-01
Showing 10 of 29 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Berube MN, Robinson SA, Wan ES, Mongiardo MA, Finer EB, Moy ML. Physical Activity and Systemic Biomarkers in Persons With COPD: Insights from a Web-Based Pedometer-Mediated Intervention. Chronic Obstr Pulm Dis. 2024 Jul 25; 11(4):369-381.View Related Profiles. PMID: 38809105; PMCID: PMC11363971; DOI: 10.15326/jcopdf.2023.0472;
     
  2. Wang Z, Koutrakis P, Liu M, Vieira CLZ, Coull BA, Maher EF, Moy ML, Huang S, Garshick E. Residential radon decay products are associated with cough and phlegm in patients with COPD. Ecotoxicol Environ Saf. 2024 Sep 01; 282:116693.View Related Profiles. PMID: 38991307
     
  3. Bamonti PM, Rose GA, Park S, Silberbogen AK, Moye J, Moy ML. Emotional Distress and Physical Activity Engagement in U.S. Veterans With Chronic Obstructive Pulmonary Disease: A Qualitative Study. Ann Behav Med. 2024 Jul 11; 58(8):539-551.View Related Profiles. PMID: 38847496
     
  4. Moy ML. Maintenance Pulmonary Rehabilitation: An Update and Future Directions. Respir Care. 2024 May 28; 69(6):724-739. PMID: 38744473; PMCID: PMC11147634; DOI: 10.4187/respcare.11609;
     
  5. Zhang CL, Maccarone JR, Grady ST, Collins CM, Moy ML, Hart JE, Kang CM, Coull BA, Schwartz JD, Koutrakis P, Garshick E. Indoor and ambient black carbon and fine particulate matter associations with blood biomarkers in COPD patients. Sci Total Environ. 2024 Jun 01; 927:171897.View Related Profiles. PMID: 38522542; PMCID: PMC11090036; DOI: 10.1016/j.scitotenv.2024.171897;
     
  6. Kraemer KM, Kilgore K, Litrownik D, Jean-Laurent B, Wayne PM, Richardson CR, Moy ML, Yeh GY. A Web-Based Mind-Body Intervention (Mindful Steps) for Promoting Walking in Chronic Cardiopulmonary Disease: Insights From a Qualitative Study. Glob Adv Integr Med Health. 2023; 12:27536130231212169. PMID: 38050584; PMCID: PMC10693791; DOI: 10.1177/27536130231212169;
     
  7. McHugh EG, Grady ST, Collins CM, Moy ML, Hart JE, Coull BA, Schwartz JD, Koutrakis P, Zhang J, Garshick E. Pulmonary, inflammatory, and oxidative effects of indoor nitrogen dioxide in patients with COPD. Environ Epidemiol. 2023 Oct; 7(5):e271.View Related Profiles. PMID: 37840862; PMCID: PMC10569754; DOI: 10.1097/EE9.0000000000000271;
     
  8. Robinson SA, Shimada SL, Sliwinski SK, Wiener RS, Moy ML. Stakeholder Perceptions of a Web-Based Physical Activity Intervention for COPD: A Mixed-Methods Study. J Clin Med. 2023 Sep 29; 12(19).View Related Profiles. PMID: 37834938; PMCID: PMC10574016; DOI: 10.3390/jcm12196296;
     
  9. Bamonti PM, Perndorfer C, Robinson SA, Mongiardo MA, Wan ES, Moy ML. Depression Symptoms and Physical Activity in Veterans With COPD: Insights From a Web-Based, Pedometer-Mediated Physical Activity Intervention. Ann Behav Med. 2023 Sep 13; 57(10):855-865.View Related Profiles. PMID: 37260290
     
  10. Robinson SA, Moy ML, Ney JP. Value of Information Analysis of a Web-Based Self-Management Intervention for Chronic Obstructive Pulmonary Disease. Telemed J E Health. 2024 Feb; 30(2):518-526.View Related Profiles. PMID: 37615601; PMCID: PMC10877383; DOI: 10.1089/tmj.2023.0010;
     
Showing 10 of 80 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 80 publications over 21 distinct years, with a maximum of 16 publications in 2021

YearPublications
20021
20031
20042
20051
20061
20081
20092
20101
20122
20133
20144
20154
20162
20171
20186
20198
20204
202116
20226
20239
20245

Contact for Mentoring:

72 E. Concord St Building A
Boston MA 02118
Google Map


Moy's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department